New Drug Technology and Drug Supervision Toxicological Research on New Drugs
New Drug Technology and Drug Supervision Toxicological Research on New Drugs, Total:31 items.
The international standard classification for "New Drug Technology and Drug Supervision Toxicological Research on New Drugs" includes: Research and development , Farming and forestry in general , Other standards related to pharmaceutics .
The Chinese standard classification for "New Drug Technology and Drug Supervision Toxicological Research on New Drugs" includes: Standardization and quality management , Medicinal herb and product , Basic standards and general methods .
Group Standards of the People's Republic of China
- T/CHAS 20-4-12-1-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-12-1: Pharmacy administration—Management of medicine-use in clinical— Pharmaceuticals under special control
- T/CHAS 20-4-2-2022 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-2: Pharmacy administration——Drug quality management and control
- T/CACM 015.9-2017 Technical specification for the management of clinical research results of traditional Chinese medicine
- T/CHAS 20-3-7-1-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 3-7-1: Pharmaceutical supply services—Key drugs management— High-alert medications
- T/CHAS 20-4-11-1-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-11-1: Pharmacy administration—Adverse drug event management— Adverse drug reaction management
- T/CHAS 20-4-12-3-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-12-3: Pharmacy administration—Management of medicine-use in clinical— antineoplastic drugs
- T/CHAS 20-4-4-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions —— Part4-4: Pharmacy administration——Automation and information technology
- T/CHAS 20-2-11-2022 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 2-11: Pharmacy practice——Therapeutic drug monitoring
- T/BLTJBX 18-2021 Novel Coronavirus Pneumonia Epidemic Prevention and Control Regulations for Retail Pharmacies
- T/SHPPA 001-2020 Guidelines for quality management of pharmaceutical research of chemical medicines
- T/CACM 015.6-2017 Training and management standards for clinical research coordinators of traditional Chinese medicine
- T/CHAS 20-4-10-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-10: Pharmacy administration—Medication use monitoring and evaluation
- T/CHAS 20-4-11-2-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-11-2: Pharmacy Management—Adverse Drug Reaction Management— Medication error management
- T/CHAS 20-3-7-4-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 3-7-4: Pharmaceutical supply services —Key medications management—Off-label uses
- T/CHAS 20-4-12-2-2023 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 4-12-2: Pharmacy administration—Management of medicine-use in clinical— Antimicrobial medicines
- T/CHAS 20-3-4-2022 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 3-4: Pharmaceutical supply services——Drug monitoring
- T/CACM 1323-2019 Standard operating procedure for Chinese medicine data monitoring committee of clinical studies
- T/CHAS 20-2-7-2021 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 2-7:PharmacyPractice—Medication Monitoring
Professional Standard - Agriculture
- 农业部630号公告-9-2006 Technical guidelines for impurity research of veterinary chemicals
- 农业部1596号公告-3-2011 Technical guidelines for safety pharmacology research of traditional Chinese medicine and natural medicine for veterinary use
国家市场监督管理总局、中国国家标准化管理委员会
- GB/T 41277-2022 Technical specification of certification for Chinese medicinal materials (medicinal plants) new breeding varieties
Yunnan Provincial Standard of the People's Republic of China
- DB53/T 607.33-2014 Flue-cured Tobacco Production Part 33: New Varieties, New Pesticides, New Technology Test Demonstration and Promotion Management
National Health Commission of the People's Republic of China
- Pharma-Guidelines-Nanodrug002 Technical Guiding Principles for Nonclinical Pharmacokinetic Research of Nanomedicines (Trial Implementation)
Liaoning Provincial Standard of the People's Republic of China
- DB21/T 2518-2015 Pharmaceutical cold chain logistics technology and management specifications
Inner Mongolia Provincial Standard of the People's Republic of China
- DB1502/T 009-2020 Novel Coronavirus Pneumonia Epidemic Prevention and Control Regulations for Retail Pharmacies
Zhejiang Provincial Standard of the People's Republic of China
- DB33/T 713-2008 Technology and management specification for drug cold chain logistics
RU-GOST R
- GOST R 56702-2015 Medicines for medical applications. Nonclinical toxicology and pharmacokinetic studies of safety
- GOST R 56700-2015 Medicines for medical applications. Safety Pharmacology studies for human pharmaceuticals
SCC
- UNE 166006:2006 EX R&D&i management: Technological Watch System
- AENOR UNE 166008:2012 R&D&i management: Technology transfer.
- AENOR UNE 166000:2006 R&D&I Management: Terminology and definitions of R&D&I activities.
